Phenylbenzenesulfonates and -sulfonamides as 17β-hydroxysteroid dehydrogenase type 2 inhibitors: Synthesis and SAR-analysis
作者:Anna Vuorinen、Roger T. Engeli、Susanne Leugger、Christoph R. Kreutz、Daniela Schuster、Alex Odermatt、Barbara Matuszczak
DOI:10.1016/j.bmcl.2017.05.005
日期:2017.7
in multiple studies, synthesis and biological evaluation of promising 17β-HSD2 inhibitors have been reported. Our previous work led to the identification of phenylbenzenesulfonamides and -sulfonates as new 17β-HSD2 inhibitors by ligand-based pharmacophore modeling and virtual screening. In this study, new molecules representing this scaffold were synthesized and tested in vitro for their 17β-HSD2 activity
2型17β-羟基类固醇脱氢酶(17β-HSD2)将有效的雌激素雌二醇转化为弱活性的酮形式雌酮。由于其在骨中的表达,抑制17β-HSD2为治疗骨质疏松症提供了一种有吸引力的策略,该病症通常是由于活性性类固醇减少而引起的。当前,市场上没有靶向17β-HSD2的药物,但是在多项研究中,已经报道了有前途的17β-HSD2抑制剂的合成和生物学评估。通过基于配体的药效团建模和虚拟筛选,我们以前的工作导致鉴定出新的17β-HSD2抑制剂苯基苯磺酰胺和-磺酸盐。在这项研究中,代表该支架的新分子被合成并在体外测试 为他们的17β-HSD2活性推导更深刻的构效关系规则。